HEMATOLOGIC
MALIGNANCIES

MEMBERSHIP RESOURCES

BECOME A MEMBER

EVENTS

VIEW EVENTS

Program Highlights

November 2024

CRISPR screens unveil nutrient-dependent lysosomal and mitochondrial nodes impacting intestinal tissue-resident memory CD8+ T cell formation

October 2024

Droplet Hi-C enables scalable, single-cell profiling of chromatin architecture in heterogeneous tissues

October 2024

Orientation-dependent CD45 inhibition with viral and engineered ligands

Inside the Lab: Researcher Spotlight with Hojun Li, MD, PhD

Watch Now

Overview

The Hematologic Malignancies (HEM) research program focuses on advancing our understanding of molecular pathogenesis and treatment of leukemias and lymphomas.Learn more about the program & goals

Leadership

Leslie A. Crews, PhD

Professor of Medicine
Assistant Professor, Division of Regenerative Medicine, UC San Diego, School of Medicine
Member, Moores Cancer Center

Email: lcrews@ucsd.edu

Thomas Kipps, MD/PhD

Professor of Medicine
Evelyn & Edwin Tasch Chair, Cancer Research
Deputy Director of Research Operations, Moores Cancer Center
Phone: 858-534-5400
Email: tkipps@health.ucsd.edu

HEMATOLOGIC MALIGNANCIES